N-Terminal Prohormone of Brain Natriuretic Peptide (One step test for NT -pro BNP )
- UID
- IMP/IVD/2020/000236_5b6607e060667f7999cf51328008a48b_0b5a3f17d26f626dabc7068256eeeb84
- Device class
- Class C
- Brand name
- Beta 2 - MG
- License holder
- Cosmic Scientific Technologies
- Approving authority
- CDSCO
- Product information
- One step test for NT -pro BNP/cTnl (Beta 2 - MG) is intended for in vitro quantitative determination of N terminal B type natriuretic peptide precursor/cardiac troponin I (Beta 2 - MG) in serum, plasma and whole blood. This test is used as an aid in the clinical diagnosis, prognosis and evaluation of Heart Failure (Beta 2 - MG), Acute Myocardial Infarction (Beta 2 - MG) and Acute Coronary Syndrome (Beta 2 - MG)
N-Terminal Prohormone of Brain Natriuretic Peptide (One step test for NT -pro BNP ) is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2020/000236_5b6607e060667f7999cf51328008a48b_0b5a3f17d26f626dabc7068256eeeb84. This device is marketed under the brand name Beta 2 - MG. The license holder is Cosmic Scientific Technologies, and it is classified as Device Class Class C. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.